Generative AI-Driven Storytelling: A New Era for Marketing

This paper delves into the transformative power of Generative AI-driven storytelling in the realm of marketing. Generative AI, distinct from traditional machine learning, offers the capability to craft narratives that resonate with consumers on a deeply personal level. Through real-world examples from industry leaders like Google, Netflix and Stitch Fix, we elucidate how this technology shapes marketing strategies, personalizes consumer experiences, and navigates the challenges it presents. The paper also explores future directions and recommendations for generative AI-driven storytelling, including prospective applications such as real-time personalized storytelling, immersive storytelling experiences, and social media storytelling. By shedding light on the potential and impact of generative AI-driven storytelling in marketing, this paper contributes to the understanding of this cutting-edge approach and its transformative power in the field of marketing.Comment: 17 pages, 2 figure

The Impact of Generative AI on the Future of Visual Content Marketing

In today's world of marketing, it is necessary to have visually appealing content. Visual material has become an essential area of focus for every company as a result of the widespread availability of gadgets for mass communication and extended visual advancements. Similarly, artificial intelligence is also gaining ground and it is proving to be the most revolutionary technological advancement thus far. The integration of visual content with artificial intelligence is the key to acquiring and retaining loyal customers; its absence from the overarching marketing strategy of any production raises a red flag that could ultimately result in a smaller market share for that company.Comment: 15 pages, 5 figure

Metabolic side-effects of novel antipsychotic drugs

Prvi opisani slučajevi metaboličkih nuspojava antipsihotika potječu još od vremena kada se ti lijekovi uvode u kliničku upotrebu, tj. sredinom pedesetih godina prošlog stoljeća. Pokazalo se, međutim, da se metaboličke nuspojave ne javljaju samo kod primjene konvencionalnih antipsihotika, poput klorpromazina. Danas smo suočeni sa sličnim problemima kod primjene novijih, takozvanih atipičnih antipsihotika. Uvođenje atipičnih antipsihotika u terapiju bitno je unaprijedilo liječenje bolesnika sa shizofrenijom i ostalim psihotičnim poremećajima. Glavna prednost ovih lijekova u odnosu na konvencionalne antipsihotike je manja učestalost ekstrapiramidnih nuspojava, kao i hiperprolaktinemije, te sveukupno bolja podnošljivost. Ipak, neki od atipičnih antipsihotika povezuju se s porastom tjelesne težine, pojavom šećerne bolesti i porastom vrijednosti kolesterola i triglicerida. Ovaj se pregled bavi razlikama u djelovanju pojedinih atipičnih antipsihotika na homeostazu glukoze i inzulina te metabolizam lipida, kao i pitanjem na koji način racionalno primjenjivati antipsihotike kod kojih se javljaju metaboličke nuspojave. Odnosno, daju se preporuke, po prvi put u Hrvatskoj, za svakodnevni klinički rad o tome kako nadzirati metabolički status bolesnika liječenih novijim antipsihoticima.First descriptions of metabolic side-effects of antipsychotic drugs date back to the 1950s when these drugs were introduced. In the meantime, metabolic side-effects have been shown to occur not only during therapy including conventional antipsychotics like chlorpromazine. Presently, similar problems are encountered with application of the novel, so-called atypical antipsychotics. Introduction of atypical antipsychotics in therapy has substantially promoted the treatment of patients with schizophrenia and other psychotic disorders. Major advantage of these drugs in comparison to conventional antipsychotics is lower frequency of extra pyramidal side-effects and hyperprolactinemia, and generally better tolerance. Still, some atipical antipsychotics are associated to body weight gain, occurrence of diabetes, and elevated cholesterol and triglyceride concentrations. This review addresses differences in effect of certain atypical antipsychotics on glucose and insulin homeostasis and lipid metabolism, as well as the question of the rational method of applying antipsychotics that are accompanied by metabolic side-effects. For the first time in Croatia, this article provides recommendations for routine clinical practice, i.e. on the monitoring of metabolic status of patients treated by novel antipsychotics

Charge controller in PV system

U ovom radu opisani su regulatori punjenja i baterije koje se koriste u fotonaponskim sustavima. U drugom poglavlju navedene su vrste baterija i parametri koji utječu na njihov odabir. Opisane su prednosti i nedostaci svakog od tipova kao i proces starenja baterija. U trećem poglavlju opisani su regulatori punjenja. Navedeni su algoritmi koji se najčešće koriste u MPPT regulatorima. U sljedećem poglavlju izmjerene su vrijednosti struje i napona tijekom punjenja različitih tipova baterija. Rezultati su prikazani dijagramima. U petom poglavlju simulirani su valni oblici silaznog pretvarača primjenjivog u fotonaponskom sustavu. Simulirani su i valni oblici struje i napona tijekom punjenja litij-ionske baterije te su rezultati dobiveni mjerenjem potvrđeni.This paper describes charge controller and batteries used in photovalic systems. The second chapter lists battery types and parameters that affect their choice. The advantages and disadvantages of each type as well as the battery aging process are described. Charge controllers and buck converter are described in the third chapter. The charge regulators are divided into PWM and MPPT regulators. Algorithms commonly used by MPPT regulators are analyzed. In the fourth chapter, charging techniques for different types of batteries are compared. The current and voltage values were measured while charging the battery. In the next chapter the current and voltage values were simulated while charging the battery. The results of measurements and simulations have been compared

Charge controller in PV system

U ovom radu opisani su regulatori punjenja i baterije koje se koriste u fotonaponskim sustavima. U drugom poglavlju navedene su vrste baterija i parametri koji utječu na njihov odabir. Opisane su prednosti i nedostaci svakog od tipova kao i proces starenja baterija. U trećem poglavlju opisani su regulatori punjenja. Navedeni su algoritmi koji se najčešće koriste u MPPT regulatorima. U sljedećem poglavlju izmjerene su vrijednosti struje i napona tijekom punjenja različitih tipova baterija. Rezultati su prikazani dijagramima. U petom poglavlju simulirani su valni oblici silaznog pretvarača primjenjivog u fotonaponskom sustavu. Simulirani su i valni oblici struje i napona tijekom punjenja litij-ionske baterije te su rezultati dobiveni mjerenjem potvrđeni.This paper describes charge controller and batteries used in photovalic systems. The second chapter lists battery types and parameters that affect their choice. The advantages and disadvantages of each type as well as the battery aging process are described. Charge controllers and buck converter are described in the third chapter. The charge regulators are divided into PWM and MPPT regulators. Algorithms commonly used by MPPT regulators are analyzed. In the fourth chapter, charging techniques for different types of batteries are compared. The current and voltage values were measured while charging the battery. In the next chapter the current and voltage values were simulated while charging the battery. The results of measurements and simulations have been compared

Charge controller in PV system

U ovom radu opisani su regulatori punjenja i baterije koje se koriste u fotonaponskim sustavima. U drugom poglavlju navedene su vrste baterija i parametri koji utječu na njihov odabir. Opisane su prednosti i nedostaci svakog od tipova kao i proces starenja baterija. U trećem poglavlju opisani su regulatori punjenja. Navedeni su algoritmi koji se najčešće koriste u MPPT regulatorima. U sljedećem poglavlju izmjerene su vrijednosti struje i napona tijekom punjenja različitih tipova baterija. Rezultati su prikazani dijagramima. U petom poglavlju simulirani su valni oblici silaznog pretvarača primjenjivog u fotonaponskom sustavu. Simulirani su i valni oblici struje i napona tijekom punjenja litij-ionske baterije te su rezultati dobiveni mjerenjem potvrđeni.This paper describes charge controller and batteries used in photovalic systems. The second chapter lists battery types and parameters that affect their choice. The advantages and disadvantages of each type as well as the battery aging process are described. Charge controllers and buck converter are described in the third chapter. The charge regulators are divided into PWM and MPPT regulators. Algorithms commonly used by MPPT regulators are analyzed. In the fourth chapter, charging techniques for different types of batteries are compared. The current and voltage values were measured while charging the battery. In the next chapter the current and voltage values were simulated while charging the battery. The results of measurements and simulations have been compared

Kapusova sovka (Mamestra brassicae [L.]) in zelenjadna sovka (Mamestra oleracea [L.]) - predstavitev vrst in ukrepov za njihovo spremljanje in zatiranje

Cabbage moth (Mamestra brassicae L.) and bright-line brown-eyes moth (Mamestra oleracea L.) - presentation of the species, their monitoring and control measure

Metabolic side-effects of novel antipsychotic drugs

Prvi opisani slučajevi metaboličkih nuspojava antipsihotika potječu još od vremena kada se ti lijekovi uvode u kliničku upotrebu, tj. sredinom pedesetih godina prošlog stoljeća. Pokazalo se, međutim, da se metaboličke nuspojave ne javljaju samo kod primjene konvencionalnih antipsihotika, poput klorpromazina. Danas smo suočeni sa sličnim problemima kod primjene novijih, takozvanih atipičnih antipsihotika. Uvođenje atipičnih antipsihotika u terapiju bitno je unaprijedilo liječenje bolesnika sa shizofrenijom i ostalim psihotičnim poremećajima. Glavna prednost ovih lijekova u odnosu na konvencionalne antipsihotike je manja učestalost ekstrapiramidnih nuspojava, kao i hiperprolaktinemije, te sveukupno bolja podnošljivost. Ipak, neki od atipičnih antipsihotika povezuju se s porastom tjelesne težine, pojavom šećerne bolesti i porastom vrijednosti kolesterola i triglicerida. Ovaj se pregled bavi razlikama u djelovanju pojedinih atipičnih antipsihotika na homeostazu glukoze i inzulina te metabolizam lipida, kao i pitanjem na koji način racionalno primjenjivati antipsihotike kod kojih se javljaju metaboličke nuspojave. Odnosno, daju se preporuke, po prvi put u Hrvatskoj, za svakodnevni klinički rad o tome kako nadzirati metabolički status bolesnika liječenih novijim antipsihoticima.First descriptions of metabolic side-effects of antipsychotic drugs date back to the 1950s when these drugs were introduced. In the meantime, metabolic side-effects have been shown to occur not only during therapy including conventional antipsychotics like chlorpromazine. Presently, similar problems are encountered with application of the novel, so-called atypical antipsychotics. Introduction of atypical antipsychotics in therapy has substantially promoted the treatment of patients with schizophrenia and other psychotic disorders. Major advantage of these drugs in comparison to conventional antipsychotics is lower frequency of extra pyramidal side-effects and hyperprolactinemia, and generally better tolerance. Still, some atipical antipsychotics are associated to body weight gain, occurrence of diabetes, and elevated cholesterol and triglyceride concentrations. This review addresses differences in effect of certain atypical antipsychotics on glucose and insulin homeostasis and lipid metabolism, as well as the question of the rational method of applying antipsychotics that are accompanied by metabolic side-effects. For the first time in Croatia, this article provides recommendations for routine clinical practice, i.e. on the monitoring of metabolic status of patients treated by novel antipsychotics